Work

Embolization of a fluoropolymer-coated left atrial appendage occlusion device to the infrarenal aorta presenting with acute neurologic symptoms: A case report

Year: 2026

Type: article

Abstract: Transcatheter left atrial appendage occlusion is now widely performed in the United States using two FDA-approved device platforms: the WATCHMAN series and the Amplatzer Amulet.1–6 Although procedural success rates are high, device-related complications remain recognized risks. Pericardial effusion represents the most common serious procedural complication, while device embolization occurs in approximately 0.2–0.7% of cases and is typically related to malpositioning, suboptimal sizing, or unfavorable appendage anatomy.

Source: HeartRhythm Case Reports

DOI: 10.1016/j.hrcr.2026.07.023

Authors: Tate Barney, Jacob Weaver, Nathaniel Dusini, Naveen Thota

Institution: Wright State University

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,100